Nosocomial Infection by Sequence Type 357 Multidrug-Resistant Acinetobacter baumannii Isolates in a Neonatal Intensive Care Unit in Daejeon, Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acinetobacter baumannii is an important microorganism responsible for a number of nosocomial outbreaks, in particular, in intensive care units (ICUs). We investigated a nosocomial infection caused by multidrug-resistant (MDR) A. baumannii in a neonatal intensive care unit (NICU) in Korea. A. baumannii isolates were characterized using Etest (AB Biodisk, Sweden), two multiplex PCR assays, and multilocus sequence typing (MLST)scheme. PCR and PCR mapping experiments were performed for detecting and characterizing the determinants of antimicrobial resistance. Eight strains isolated from an NICU belonged to European (EU) clone II and revealed only one sequence type (ST), namely,ST357. All the isolates were susceptible to imipenem but were resistant to amikacin, gentamicin,ceftazidime, cefepime, and ciprofloxacin. To the best of our knowledge, this is the first report of a nosocomial infection in an NICU in Korea caused by ST357 MDR/carbapenem-susceptible A. baumannii strains. This result demonstrates that nosocomial outbreaks of MDR/carbapenem-susceptible strains as well as MDR/carbapenem-resistant isolates may occur in NICUs.
Abstract
Acinetobacter baumannii is an important microorganism responsible for a number of nosocomial outbreaks, in particular, in intensive care units (ICUs). We investigated a nosocomial infection caused by multidrug-resistant (MDR) A. baumannii in a neonatal intensive care unit (NICU) in Korea. A. baumannii isolates were characterized using Etest (AB Biodisk, Sweden), two multiplex PCR assays, and multilocus sequence typing (MLST)scheme. PCR and PCR mapping experiments were performed for detecting and characterizing the determinants of antimicrobial resistance. Eight strains isolated from an NICU belonged to European (EU) clone II and revealed only one sequence type (ST), namely,ST357. All the isolates were susceptible to imipenem but were resistant to amikacin, gentamicin,ceftazidime, cefepime, and ciprofloxacin. To the best of our knowledge, this is the first report of a nosocomial infection in an NICU in Korea caused by ST357 MDR/carbapenem-susceptible A. baumannii strains. This result demonstrates that nosocomial outbreaks of MDR/carbapenem-susceptible strains as well as MDR/carbapenem-resistant isolates may occur in NICUs.
참고문헌 (16)
- Peleg AY, "Acinetobacter baumannii: emergence of a successful pathogen", Clin Microbiol Rev, 21, pp.538~582 (2008)
- Wisplinghoff H, "Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility", Clin Infect Dis, 31, pp.690~697 (2000)
- Villegas MV, "Acinetobacter outbreaks, 1977-2000", Infect Control Hosp Epidemiol, 24, pp.284~295 (2003)
- Garnacho-Montero J, "Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings", Intensive Care Med, 31, pp.649~655 (2005)
- Touati A, "Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis", Ann Epidemiol, 19, pp.372~378 (2009)
- Gundi VA, "Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species", Microbiology, 155, pp.2333~2341 (2009)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Fifteenth Informational supplement, M100–S20" (2010), Clinical and Laboratory Standards Institute
- Turton JF, "Use of sequence- based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii", Clin Microbiol Infect, 13, pp.807~815 (2007)
- Bartual SG, "Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii", J Clin Microbiol, 43, pp.4382~4390 (2005)
- Bou G, "PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii", Clin Microbiol Infect, 6, pp.635~643 (2000)
- 구선회, "Genetic Basis of Multidrug-resistant Acinetobacter baumannii Clinical Isolates from Three University Hospitals in Chungcheong Province, Korea", Annals of Laboratory Medicine, 30(5), pp.498~506 (2010), 대한진단검사의학회
- Cho YJ, "Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 64, pp.185~190 (2009), ELSEVIER SCIENCES INC
- Zhou Y, "Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with highlevel resistance to aminoglycosides", Eur J Clin Microbiol Infect Dis, 29, pp.1349~1353 (2010)
- Akasaka T, "Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance", Antimicrob Agents Chemother, 45, pp.2263~2268 (2001)
- Valentine SC, "Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California", J Clin Microbiol, 46, pp.2499~2507 (2008)
- McGrath EJ, "An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control", Infect Control Hosp Epidemiol, 32, pp.34~41 (2011)